Humalog Mix 50 Kwikpen 100IU/ml

Humalog Mix 50 Kwikpen 100IU/ml is used to treat type 1 and type 2 diabetes mellitus. In diabetes mellitus type I, the body does not produce enough insulin to regulate blood sugar levels. In diabetes mellitus type II, either the body stops producing enough insulin (the hormone which helps decrease sugar levels in the blood) or there is resistance to the action of insulin. As a result, insulin is produced in large amounts, leading to high blood glucose levels.

Humalog Mix 50 Kwikpen 100IU/ml is a combination medicine that suppress the production of sugar in the liver and facilitate the reuptake of sugar in the fat and muscle cells. Together, Humalog Mix 50 Kwikpen 100IU/ml confirms stable sugar control.

Not everyone who is taking Humalog Mix 50 Kwikpen 100IU/ml will get these side effects. You may experience rash, injection site allergic reaction, weight gain, edema (tissue swelling or fluid overload), skin thickening at the injection site, low blood glucose levels, and itching. Most of these side effects of Humalog Mix 50 Kwikpen 100IU/ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Humalog Mix 50 Kwikpen 100IU/ml should be taken 15 minutes before food or as advised by your doctor. It should be administered subcutaneously (in the upper thigh, abdomen, upper arm, or buttocks) only. Your doctor will explain how to inject the medicine by your own. However, if it is difficult to inject the medicine, ask a healthcare professional to administer it. 

Inform your doctor if you are allergic to Humalog Mix 50 Kwikpen 100IU/ml. Do not take Humalog Mix 50 Kwikpen 100IU/ml if you have low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol. Try not to stop receiving Humalog Mix 50 Kwikpen 100IU/ml of your own. Let your doctor know about this, as it may cause withdrawal symptoms. Humalog Mix 50 Kwikpen 100IU/ml is a cold chain medicine, and so it must be stored in the refrigerator between 2-8 degrees Celsius. Do not store in the freezer or the fridge.

Humalog Mix 50 Kwikpen 100IU/ml is used in the treatment of Type 1 and type 2 Diabetes mellitus. The detailed uses of Humalog Mix 50 Kwikpen 100IU/ml are as follows:

• Type 1 Diabetes Mellitus: Humalog Mix 50 Kwikpen 100IU/ml provides both rapid and intermediate insulin coverage to mimic natural insulin secretion.
• Type 2 Diabetes Mellitus: Humalog Mix 50 Kwikpen 100IU/ml is used when oral medications are insufficient to control blood sugar levels.
• Combination Therapy: Humalog Mix 50 Kwikpen 100IU/ml may be used alongside other oral antidiabetic medications to achieve improved blood sugar control, offering a comprehensive approach to diabetes management.

• Follow your doctor's instructions carefully regarding the dosage and duration of your treatment.
• Humalog Mix 50 Kwikpen 100IU/ml is injected under the skin. A healthcare provider can demonstrate how to properly administer the medication on your own.
• This medication should never be injected intravenously or directly into a vein.
• Avoid injecting this medicine into skin that is damaged, tender, bruised, thickened, scaly, pitted, or has scars or hard lumps.

• Humalog Mix 50 Kwikpen 100IU/ml belongs to the class of medications called ‘antidiabetics’ primarily used to improve blood sugar control in adults with diabetes mellitus.
• Insulin is a hormone that works by lowering glucose levels (sugar) in the blood.
• Humalog Mix 50 Kwikpen 100IU/ml helps in improving the glycemic control, which in turn decreases the risk of progression of complications of diabetes like damage of the retina, damage to the kidney, damage to nerve cells, delayed wound healing, diabetic foot ulcer and others.
• Humalog Mix 50 Kwikpen 100IU/ml offers the flexibility to adjust insulin intake based on carbohydrate consumption and blood glucose levels, ensuring tailored diabetes management. The
• The Penfill format facilitates precise and convenient dosing using an insulin pen device, thereby enhancing the ease of use for diabetic patients.
• Humalog Mix 50 Kwikpen 100IU/ml starts to work within 10 minutes after injection, peaks in 2 hours and keeps working for up to 24 hours. Thereby it controls and maintains the glucose levels in the body throughout the day.

• Inform your doctor if you are allergic to Humalog Mix 50 Kwikpen 100IU/ml.
• Do not take Humalog Mix 50 Kwikpen 100IU/ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription or recreational drugs.
• Try not to stop receiving Humalog Mix 50 Kwikpen 100IU/ml of your own. Please inform your doctor about this, as it may cause withdrawal symptoms.
• Humalog Mix 50 Kwikpen 100IU/ml may decrease the level of potassium, leading to a state of hypokalemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma, and even death.
• Humalog Mix 50 Kwikpen 100IU/ml is for subcutaneous (under the skin) use only.
• If you are switching to a different insulin brand or using a different method of injection, it should be done under strict medical supervision.
• Cases of heart failure have been reported when pioglitazone was used with insulin, especially in patients at high risk of cardiac heart failure.
• The first symptoms of hyperglycemia (high blood sugar levels) may include excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite, and an acetone odour in the breath. You should closely monitor these symptoms.
• It is advisable not to consume alcohol, as it may either increase or decrease your blood glucose level.
• Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule.
• Humalog Mix 50 Kwikpen 100IU/ml is a cold chain medicine, and therefore it must be stored in the refrigerator at a temperature between 2 °C and 8 °C; otherwise, its efficiency may be compromised. Do not store in the freezer or the fridge.
• Humalog Mix 50 Kwikpen 100IU/ml should not be administered intravenously (into the vein).